WORK Medical Technology Group LTD Ordinary Shares (WOK) - Net Assets
Based on the latest financial reports, WORK Medical Technology Group LTD Ordinary Shares (WOK) has net assets worth $21.17 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($33.16 Million) and total liabilities ($11.99 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read WORK Medical Technology Group LTD Ordina (WOK) financial obligations for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $21.17 Million |
| % of Total Assets | 63.84% |
| Annual Growth Rate | 29.0% |
| 5-Year Change | 85.81% |
| 10-Year Change | N/A |
| Growth Volatility | 34.95 |
WORK Medical Technology Group LTD Ordinary Shares - Net Assets Trend (2020–2025)
This chart illustrates how WORK Medical Technology Group LTD Ordinary Shares's net assets have evolved over time, based on quarterly financial data. Also explore total assets of WORK Medical Technology Group LTD Ordina for the complete picture of this company's asset base.
Annual Net Assets for WORK Medical Technology Group LTD Ordinary Shares (2020–2025)
The table below shows the annual net assets of WORK Medical Technology Group LTD Ordinary Shares from 2020 to 2025. For live valuation and market cap data, see WORK Medical Technology Group LTD Ordina (WOK) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $21.17 Million | +31.74% |
| 2024-09-30 | $16.07 Million | +46.28% |
| 2023-09-30 | $10.99 Million | -1.83% |
| 2022-09-30 | $11.19 Million | -1.79% |
| 2021-09-30 | $11.39 Million | +92.22% |
| 2020-09-30 | $5.93 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to WORK Medical Technology Group LTD Ordinary Shares's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 5.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $4.96 Million | 27.03% |
| Common Stock | $51.80K | 0.28% |
| Other Comprehensive Income | $291.00K | 1.59% |
| Other Components | $13.04 Million | 71.10% |
| Total Equity | $18.35 Million | 100.00% |
WORK Medical Technology Group LTD Ordinary Shares Competitors by Market Cap
The table below lists competitors of WORK Medical Technology Group LTD Ordinary Shares ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Lazydays Holdings Inc
NASDAQ:GORV
|
$1.57 Million |
|
Anatara Lifesciences Ltd
AU:ANR
|
$1.57 Million |
|
Clearmind Medicine Inc. Common Shares
NASDAQ:CMND
|
$1.58 Million |
|
Duke Royalty Ltd
LSE:DUKE
|
$1.58 Million |
|
Trufin PLC
LSE:TRU
|
$1.57 Million |
|
BioSenic S.A.
BR:BIOS
|
$1.57 Million |
|
Foxtons Group Plc
LSE:FOXT
|
$1.57 Million |
|
Shirpur Gold Refinery Limited
NSE:SHIRPUR-G
|
$1.56 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in WORK Medical Technology Group LTD Ordinary Shares's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 13,185,926 to 18,345,191, a change of 5,159,265 (39.1%).
- Net loss of 1,072,667 reduced equity.
- New share issuances of 6,900,912 increased equity.
- Other comprehensive income decreased equity by 200,266.
- Other factors decreased equity by 468,714.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.07 Million | -5.85% |
| Share Issuances | $6.90 Million | +37.62% |
| Other Comprehensive Income | $-200.27K | -1.09% |
| Other Changes | $-468.71K | -2.55% |
| Total Change | $- | 39.13% |
Book Value vs Market Value Analysis
This analysis compares WORK Medical Technology Group LTD Ordinary Shares's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-09-30 | $33.80 | $1.29 | x |
| 2021-09-30 | $69.24 | $1.29 | x |
| 2022-09-30 | $64.52 | $1.29 | x |
| 2023-09-30 | $68.11 | $1.29 | x |
| 2024-09-30 | $102.14 | $1.29 | x |
| 2025-09-30 | $6330.29 | $1.29 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently WORK Medical Technology Group LTD Ordinary Shares utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -5.85%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -10.89%
- • Asset Turnover: 0.30x
- • Equity Multiplier: 1.81x
- Recent ROE (-5.85%) is below the historical average (10.09%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 23.75% | 2.22% | 0.93x | 11.47x | $673.86K |
| 2021 | 59.34% | 12.99% | 1.50x | 3.05x | $4.95 Million |
| 2022 | 8.65% | 4.39% | 0.77x | 2.55x | $-134.87K |
| 2023 | 1.13% | 0.83% | 0.45x | 3.03x | $-875.60K |
| 2024 | -26.49% | -30.35% | 0.32x | 2.75x | $-4.81 Million |
| 2025 | -5.85% | -10.89% | 0.30x | 1.81x | $-2.91 Million |
Industry Comparison
This section compares WORK Medical Technology Group LTD Ordinary Shares's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,432,799,891
- Average return on equity (ROE) among peers: -74.29%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| WORK Medical Technology Group LTD Ordinary Shares (WOK) | $21.17 Million | 23.75% | 0.57x | $1.57 Million |
| Abbott Laboratories (ABT) | $24.16 Billion | 9.46% | 0.81x | $155.56 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-13.54K | 0.00% | 0.00x | $21.60 Million |
| Aethlon Medical Inc (AEMD) | $9.29 Million | -84.45% | 0.15x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $105.73 Million | -116.68% | 0.61x | $903.35K |
| Adapthealth Corp (AHCO) | $15.14 Million | -140.98% | 14.05x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $2.15 Million | -112.84% | 0.45x | $16.04 Million |
| Allurion Technologies, Inc. (ALUR) | $-70.49 Million | 0.00% | 0.00x | $8.60 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.22 Million |
| Artivion Inc (AORT) | $89.39 Million | 8.74% | 0.25x | $1.73 Billion |
| Apyx Medical Inc (APYX) | $21.15 Million | 2.82% | 0.30x | $125.55 Million |
About WORK Medical Technology Group LTD Ordinary Shares
WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anes… Read more